Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 53
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Prairie falcons – uncertain kinship in an uncertain climate?

Predicting the effects of climate change on species at the top trophic levels is crucial because they can...

Are male daddy-longlegs becoming "endangered?"

Most animal species have populations with equal ratios of males and females, but some have naturally biased...

Water Purification for Developing Countries

Each year, more than 3.5 million people die from lack of access to clean water in developing countries...

Backer Badge Funded